Neuroepidemiology

Neuroepidemiology is a branch of epidemiology involving the study of neurological disease distribution and determinants of frequency in human populations. The term was first introduced by Dr. Len Kurland, Dr. Milton Alter and Dr. John F. Kurtzke in 1967.[1] Traditionally, neuroepidemiology has been perceived for a long time as a science of incidence, prevalence, risk factors, natural history and prognosis of neurological disorders. However, this is only one part of neuroepidemiology, called non-experimental neuroepidemiology. The other integral, but commonly forgotten, part of neuroepidemiology is experimental neuroepidemiology, which is research based on clinical trials of effectiveness or efficacy of various interventions in neurological disorders.

For the journal, see Neuroepidemiology (journal).

Publications

In 1982, Karger set up a new journal entitled "[2]".[3] This periodical is the only international journal devoted to the study of neurological disease distribution and determinants of frequency in human populations.

Since the time of its inception in 1982, the scope of "Neuroepidemiology" journal has evolved considerably. At present, the journal publishes manuscripts on all aspects of epidemiology of neurological disorders, including clinical trials and systematic reviews.[4] Its primary focus is on chronic and acute neurological disorders of major importance to clinical medicine, public health, and health care delivery. The journal also welcomes manuscripts dealing with methodological issues in neuroepidemiological studies. In 2017, Dr. George Jelinek, Head of the Neuroepidemiology Unit at The University of Melbourne, and founder of Overcoming Multiple Sclerosis, LTD, an Australian not-for-profit organization[5] was posted as Specialty Chief Editor of Frontiers in Neurology section.

Congresses

To reflect modern achievements in our knowledge in non-experimental and experimental (clinical trials) epidemiology of neurological disorders, the First International Congress of Clinical Neuroepidemiology is planned to be held in 2009. This International Congress, for the first time, will bring together scientists and experts in all major fields of experimental and non-experimental neuroepidemiology. Combining scientific sessions in these two interrelated fields of neuroepidemiology with two corresponding half-day teaching courses and a one year-free on-line subscription to the journal of "Neuroepidemiology" for all registered participants are additional unique features of the Congress.

The main topics of the Congress that will be addressed during plenary, platform and poster sessions include stroke, TIA, dementia, Parkinson’s disease, multiple sclerosis, epilepsy, migraine, traumatic brain injury, peripheral neuropathy, neuromuscular disorders, central nervous system infections and tumours, neurological aspects of aging, neuropsychology and neuropsychiatric disorders. The Congress will feature internationally recognized invited speakers, platform lectures, short oral presentations and poster sessions, and will provide an ideal platform for continuing education in all fields of experimental and non-experimental clinical neuroepidemiology.

To reflect modern achievements in our knowledge in non-experimental and experimental (clinical trials) epidemiology of neurological disorders, the First International Congress of Clinical Neuroepidemiology will be held in Munich, Germany on August 27–30, 2009 (www.neuro2009.com). This International Congress, for the first time, will bring together scientists and experts in all major fields of experimental and non-experimental neuroepidemiology. Combining scientific sessions in these two interrelated fields of neuroepidemiology with two corresponding half-day teaching courses and a one year-free on-line subscription to the journal of "Neuroepidemiology" for all registered participants are additional unique features of the Congress.

The main topics of the Congress that will be addressed during plenary, platform and poster sessions include stroke, TIA, dementia, Parkinson’s disease, multiple sclerosis, epilepsy, migraine, traumatic brain injury, peripheral neuropathy, neuromuscular disorders, central nervous system infections and tumours, neurological aspects of aging, neuropsychology and neuropsychiatric disorders. The Congress will feature internationally recognized invited speakers, platform lectures, short oral presentations and poster sessions, and will provide an ideal platform for continuing education in all fields of experimental and non-experimental clinical neuroepidemiology.

Programs and training

Several institutions in the United States offer formal training and research experience in neuroepidemiology, including:

  • Training scholarships are offered for pre- and post-doctoral scholars by the Epidemiology Department at the University of Pittsburgh Graduate School of Public Health[6]
  • The Neuroepidemiology Training Program offered by the Columbia University Mailman School of Public Health,[7] and
  • The University of Maryland Neuroepidemiology Training Program.[8]

In addition, the Center for Stroke Research in the Department of Neurology and Rehabilitation at the University of Illinois College of Medicine offers a fellowship in neuroepidemiology.[9] Michigan State University also offers a neuroepidemiology fellowship as part of the International Neurologic & Psychiatric Epidemiology Program.[10]

As the field of neuroepidemiology continues to expand, research groups have developed at some of the leading medical research institutes across the United States. Currently active research groups can be found at:

Other prominent organizations such as the National Institute of Environmental Health Sciences and Kaiser Permanente have established research programs in neuroepiemiology.[15][16]

The American Academy of Neurology provides additional information on career paths in neuroepidemiology.[17]

gollark: No it's not.
gollark: No second referendum has been confirrmed.
gollark: I don't think so.
gollark: I am not currently that happy about it, but yes.
gollark: Yes.

References
  1. Dr V Feigin, personal communication with Dr J Kutrzke
  2. "Editorial Board, Frontiers in Neurololgy". Neuroepidemiology. Retrieved 5 August 2019.
  3. Neuroepidemiology
  5. "Current details for ABN 50 603 488 508". Australian Business Register. Retrieved 30 October 2018.
  6. University of Pittsburgh Graduate School of Public Health Epidemiology Department
  7. Archived 2012-12-21 at the Wayback Machine Columbia University Mailman School of Public Health Neuroepidemiology Training Program
  8. "University of Maryland School of Medicine Neuroepidmeiology Training Program". Archived from the original on 2012-11-12. Retrieved 2012-10-22.
  9. University of Illinois College of Medicine Department of Neurology and Rehabilitation Fellowship in Neuroepidemiology
  10. "Michigan State University International Neurologic & Psychiatric Epidemiology Program Neuroepidemiology Fellowship". Archived from the original on 2013-04-04. Retrieved 2012-10-22.
  11. University of Pittsburgh Graduate School of Public Health e-Brain research group
  12. "conceptual model" (PDF). Archived from the original (PDF) on 2013-07-19. Retrieved 2012-10-22.
  13. Harvard University School of Public Health Neuroepidemiology Research Group
  14. University of California, San Francisco Neuroepidemiology Research Group
  15. National Institute of Environmental Health Sciences
  16. "Kaiser Permanente". Archived from the original on 2012-03-09. Retrieved 2012-10-22.
  17. American Academy of Neurology Career Paths in Neuroepidemiology

[2] Neuroepidemiology University of Pittsburgh, Graduate School of Public Health, Department of Epidemiology

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.